China Jo-Jo Drugstores, Inc. logo
China Jo-Jo Drugstores, Inc. CJJD

China Jo-Jo Drugstores, Inc. Deferred Revenue 2011-2025 | CJJD

Deferred revenue is the amount of money or obligations that a company has received in advance for goods or services that have not yet been delivered or performed. In other words, it is income that has already been received but has not yet been recognized in accounting as revenue because the goods or services have not yet been transferred to the customer.
Features of the metric
  • Sources of future cash inflows
    A high level of deferred revenue indicates that the company has secured future cash flows, which positively affects forecasts of its financial condition and stability.
  • Assessment of operational stability
    Deferred revenue reflects demand for the company’s products or services and its ability to attract customers willing to pay in advance. It is one of the indicators of business stability and its competitive advantages.
  • Risks and obligations
    Although deferred revenue indicates future inflows, it also represents obligations that the company must fulfill. If fulfilling these obligations is delayed or impossible, it can negatively impact reputation and financial results.
  • Analysis of liquidity and cash flow
    Inflows in the form of deferred revenue improve the company’s current liquidity since the funds are already in the accounts. However, investors need to assess the ratio of deferred revenue to fulfilled obligations to understand the actual financial capabilities and risks.
  • Impact on company valuation
    In fundamental analysis, deferred revenue is taken into account for accurate revenue and profit forecasting, especially in industries with long-term contracts or subscriptions (e.g., IT sector, services, manufacturing).

Annual Deferred Revenue China Jo-Jo Drugstores, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
708 K 772 K 4.04 M 2.68 M 2.61 M 3.76 M 3.19 M 4.83 M - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
4.83 M 708 K 2.82 M

Deferred Revenue of other stocks in the Pharmaceutical retailers industry

Issuer Deferred Revenue Price % 24h Market Cap Country
Greenlane Holdings Greenlane Holdings
GNLN
3.98 M $ 3.22 7.35 % $ 24.2 M usaUSA
Trxade Group Trxade Group
MEDS
10 K - 4.55 % $ 5.8 M usaUSA
BOQI International Medical BOQI International Medical
BIMI
68 K - 6.33 % $ 5.86 M chinaChina
PetMed Express PetMed Express
PETS
2.08 M $ 2.84 -4.7 % $ 58.5 M usaUSA
LifeMD LifeMD
LFMD
8.83 M $ 3.42 -1.15 % $ 116 M usaUSA
111 111
YI
74.8 M $ 3.64 -2.67 % $ 625 M chinaChina